![](http://elea-en.com.vnct3013.avnam.net/wp-content/uploads/Render-Rabloc.png)
Rabloc
Hypolipemiant. IHMG-CoA reductase inhibitor. Indicated to treat hypercholesterolemia, dyslipidemias, dysbetalipoproteinemia and for the prevention of more severe cardiovascular events in patients at high cardiovascular risk.
Therapeutic Area
Leukotriene Receptor Antagonist + Hypolipemiant HMG-CoA reductase inhibitor
Active Ingredient
Rosuvastatine
Line
Cardiometabolism
Pharmaceutical Forms
10 mg coated tablets x 30
20 mg coated tablets x 30
![Descargar](http://elea-en.com.vnct3013.avnam.net/wp-content/themes/elea/img/arrow-blue.png)